These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12649180)

  • 1. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated receptor gamma ligands in uterine leiomyoma.
    Houston KD; Copland JA; Broaddus RR; Gottardis MM; Fischer SM; Walker CL
    Cancer Res; 2003 Mar; 63(6):1221-7. PubMed ID: 12649180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.
    Marx N; Schönbeck U; Lazar MA; Libby P; Plutzky J
    Circ Res; 1998 Nov; 83(11):1097-103. PubMed ID: 9831704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells.
    Masamune A; Kikuta K; Satoh M; Sakai Y; Satoh A; Shimosegawa T
    J Biol Chem; 2002 Jan; 277(1):141-7. PubMed ID: 11606585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone.
    Nam DH; Ramachandran S; Song DK; Kwon KY; Jeon DS; Shin SJ; Kwon SH; Cha SD; Bae I; Cho CH
    Mol Hum Reprod; 2007 Nov; 13(11):829-36. PubMed ID: 17893092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability.
    Smith SA; Monteith GR; Holman NA; Robinson JA; May FJ; Roberts-Thomson SJ
    J Neurosci Res; 2003 Jun; 72(6):747-55. PubMed ID: 12774315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
    Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.
    Galli A; Crabb D; Price D; Ceni E; Salzano R; Surrenti C; Casini A
    Hepatology; 2000 Jan; 31(1):101-8. PubMed ID: 10613734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells.
    Goetze S; Xi XP; Kawano H; Gotlibowski T; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 1999 May; 33(5):798-806. PubMed ID: 10226869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
    Clay CE; Namen AM; Atsumi G; Trimboli AJ; Fonteh AN; High KP; Chilton FH
    J Investig Med; 2001 Sep; 49(5):413-20. PubMed ID: 11523697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
    Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
    Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
    Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
    Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
    Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
    Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth dynamics of human leiomyoma cells and inhibitory effects of the peroxisome proliferator-activated receptor-gamma ligand, pioglitazone.
    Loy CJ; Evelyn S; Lim FK; Liu MH; Yong EL
    Mol Hum Reprod; 2005 Aug; 11(8):561-6. PubMed ID: 16051682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
    Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
    Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
    Burgermeister E; Tencer L; Liscovitch M
    Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.
    Marra F; Efsen E; Romanelli RG; Caligiuri A; Pastacaldi S; Batignani G; Bonacchi A; Caporale R; Laffi G; Pinzani M; Gentilini P
    Gastroenterology; 2000 Aug; 119(2):466-78. PubMed ID: 10930382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells.
    Hodges LC; Houston KD; Hunter DS; Fuchs-Young R; Zhang Z; Wineker RC; Walker CL
    Mol Cell Endocrinol; 2002 Oct; 196(1-2):11-20. PubMed ID: 12385821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.